Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Can-Fite BioPharma Ltd. buy Lokrim

Can-Fite BioPharma Ltd.
Start price
€21.80
22.02.21 / 20%
Target price
-
22.02.22
Performance (%)
-46.79%
End price
€11.60
14.11.21
Summary
This prediction ended on 14.11.21 with a price of €11.60. Massive losses of -46.79% were the result for the BUY prediction by Lokrim. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Can-Fite BioPharma Ltd. - - - -
iShares Core DAX® -1.586% 5.028% 6.332% 64.061%
iShares Nasdaq 100 -4.148% -0.125% 25.735% 86.918%
iShares Nikkei 225® -6.302% 0.528% 41.384% 77.872%
iShares S&P 500 -3.225% 0.470% 20.449% 68.192%

According to Lokrim what are the pros and cons of Can-Fite BioPharma Ltd. for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment

Comments by Lokrim for this prediction

In the thread Can-fite Biopharma Ltd. diskutieren

Buy Can-fite Biopharma Ltd.

Lokrim 
0
Report Share
22.02.21 Buy -46.79%
In the thread Trading Can-fite Biopharma Ltd.
Prediction Buy
Perf. (%) -46.79%
Target price
Change
Ends at 22.02.22

Buy beendet

Lokrim 
0
Report Share
14.11.21

Stopped prediction by Lokrim for Can-Fite BioPharma Ltd.

sell
Can-Fite BioPharma Ltd.

Start price
Target price
Perf. (%)
€11.60
14.11.21
-
14.11.22
-33.62%
15.11.22

Probably not worthwhile Investment
Lokrim 
14.11.21 20%